There is growing appreciation that ion channels do not function in isolation but rather as part of a complex and dynamic microenvironment, comprised of accessory subunits, adapter/cytoskeletal proteins and regulatory molecules. More recently, our understanding of ion channel biology has continued to develop with increasing recognition and characterization of ‘channel clustering’, or the observation that individual ion channels can form organized colocalization with one another, leading to events such as cooperative gating and/or biophysical coupling, current augmentation, and physiologic function. In this issue of Circulation Research, Baudel et al. elegantly illustrate this phenomenon occurring in the L-type voltage-gated Ca2+ channel, Cav1.2 of arterial myocytes.1 Channel clustering is identified as the mechanistic outcome of PKA-dependent phosphorylation of Cav1.2 at serine residue 1928 in the channel C-terminus leading ultimately to enhanced Ca2+ entry and vasoconstriction. Notably, this work not only reinforces previous findings of Cav1.2 clustering events, but also provides mechanistic understanding as well as physiologic significance to channel clustering events.
Voltage-gated Ca2+ channels (Cav) play important physiological roles in both excitable and non-excitable cells including neurons, atrial and ventricular myocytes, and smooth muscle.2 Cav family members respond rapidly to changes in cell membrane potential effectively gating the influx of Ca2+ ions important for ubiquitous cell functions ranging from contraction, hormone and neurotransmitter release, and activation of gene expression pathways.3 There are at least 10 known Cav isoforms across 3 major subfamilies (Cav1, Cav2, and Cav3) with unique voltage sensitivities and gating kinetics. Conserved across family members is a pore forming α-subunit comprised of a single peptide chain made up of four homologous repeats (I-IV), each containing six transmembrane regions (S1-S6). The voltage sensing domain is derived from segments S1-S4, while S5, S6, and their linker region make up the channel pore, including the selectivity filter and activation gate. The movement of the voltage sensor, in response to changes in cell membrane potential, induces a conformational change that enables channel opening and Ca2+ flux. Additional variability in channel activity is satisfied by diverse heteromeric complexing with accessory subunits β, α2δ, or γ, contributing to cell specific channel kinetics, trafficking, and regulation.4
Diversity of channel isoforms and accessory subunits promotes functional heterogeneity in the Cav family giving rise ultimately to a broad spectrum of behavior across cell types. However, even at the level of the single cell, heterogeneity has been observed within specific Cav channel populations with important implications for physiological function.5, 6 An important example of how heterogeneity arises from a single Cav populations comes from variability in the spatial distribution of Cav within the cell membrane. Specifically, organization of Cav1.2 channels in clusters at the t-tubule membrane in close apposition to ryanodine receptor Ca2+ release channels (RyR) in the sarcoplasmic reticulum (SR) underlie the phenomenon of “graded release” in cardiac myocytes whereby the amount of Ca2+ released from the SR is related to the amount of Ca2+ that comes into the myocytes through Cav1.2. Mathematical analysis reveals that in areas of channel clustering, the rate of simultaneous multi-channel openings exceeds the level predicted by binomial distributions, indicating the occurrence of cooperativity. Indeed, many investigations have suggested that if only independent channel gating occurred, then under physiologic conditions there would be an insufficient threshold of Ca2+ entry to enact physiologic processes such as excitation-contraction coupling in cardiac myocytes or tonic firing of neurons for memory and plasticity.7, 8 For Cav1.2, it is suggested that as many as 6–10 channels are capable of opening and closing simultaneously through cooperative gating, overall resulting in significantly amplified Ca2+ entry and the necessary tight spatiotemporal control needed for proper physiologic function.9
In this issue of Circulation Research, Baudel et al. apply an impressive battery of state-of-the-art imaging, electrophysiology and biochemistry techniques to comprehensively elucidate the mechanism underlying Cav1.2 clustering and cooperative gating in arteriole smooth muscle cells (Figure)1. Using a mouse model of diabetic hyperglycemia with documented alterations in Cav1.2 channel activity, the authors elegantly demonstrate how local AKAP5-dependent protein complexes10 recruit PKA activity through the nucleotide stimulated GS-coupled P2Y11 receptor resulting in the targeted phosphorylation of serine residue 1928 within the Cav1.2 C-terminus (Figure). The resulting effect led to enhanced Ca2+ entry and vasoconstriction, which could be eliminated by the phosphoablation of S1928 to alanine, the removal of AKAP5, or the pharmacologic inhibition of PKA. Through multiple superresolution imaging modalities, the authors associate the changes in augmented Ca2+ entry to the inducible and dynamic clustering of Cav1.2 channels. Consequently, these inhibitory states abrogate vasoconstriction and reduce arterial resistance in diabetic mice, demonstrating the significance of Cav1.2 cluster signaling under pathophysiologic conditions and a potent illustration of how these mechanisms might be modulated in the setting of disease.
Figure.

Schematic depicting the proposed pathway for regulation of channel clustering in arteriole myocytes via protein kinase A-dependent phosphorylation of S1928 in the Cav1.2 C-terminus. High glucose in the setting of diabetic hyperglycemia leads to activation of the P2Y11 receptor, elevated intracellular cAMP, and protein kinase A activation via a signaling microdomain organized by the A kinase anchoring protein AKAP5. Cav1.2 phosphorylation at S1928 in turn promotes channel clustering, enhanced Ca2+ influx and vasoconstriction.
Studies on Cav1.2 have contributed greatly to our general understanding of ion channel clustering as a general phenomenon important for regulation of physiological function across biology11. Evidence for channel clustering with cooperative gating and/or biophysical coupling has been observed in a host of other ion channels, including transient receptor potential (TRP) channels, multiple families of K+-channels, RyR, Inositol Trisphosphate (IP3) receptors, Hyperpolarization-Cyclic Nucleotide-Activated (HCN) channels, and voltage-gated Na+ channels (Nav).11 Beyond Cav family members, another example may be found in Nav isoforms, Nav1.1, Nav1.2, and Nav1.5, which have been demonstrated to assemble, gate, and function as dimers through interaction with the regulatory protein 14-3-3.12 This functional coupling leads to current augmentation but also allows for dominant-negative effects through coupling of WT and dysfunction (through inherited or acquired defect) channels. Although there are similarities between the type of clustering observed with Nav and Cav1.2 channels, there are important differences as well including partner proteins (AKAP5 vs. 14-3-3), degree of clustering, mode of regulation and functional effects. Taken together, however, these examples support channel clustering as a more universal mechanism for regulation of channel activity and cell membrane excitability with implications for physiology and potential therapies.
Importantly, while the study from Baudel and colleagues depicts clustering as a physiologic state necessary for proper timing and thresholding of signal generation, it also illustrates that coupled channel interactions can promote pathologic states, and that uncoupling can be an opportunity to mitigate disease. Indeed, pharmacologic blockers used to attenuate over-active channels are often met with limited success and often promote arrhythmias when exposed to the heart. Therefore, it becomes even more paramount that novel therapeutic targets of channel coupling may represent more viable strategies for attenuating channel function going forward.
Indeed, proof-of-principle data support that phospho-ablation, knockout of AKAP5, or in vitro pharmacologic treatment with the PKA inhibitor rp-cAMP limit the vasoconstrictive effects of diabetes. While these models are not readily translated into a therapeutic intervention, they reveal a novel pathway for future investigation into translational targeting. A potential translational avenue to explore going forward is in peptide-based strategies. For example, peptide-based approaches to inhibit PKA using engineered versions of the endogenous PKA regulatory element PKI are currently being developed.13 Additionally, studies using artificial expression of just the C-terminal fragment of Cav1.2 showed its role as potent vasodilator, likely serving as a competitive decoy sufficient for interaction but without the corresponding contribution to cooperative gating.14 Certainly, like any therapeutic compound, potential challenges like effective delivery, tissue and cell specificity and off target effects will need to be addressed, particularly given the global expression for many of the players and occurrences of channel coupling.
Although the new findings from the Baudel group provide important insight into the mechanistic pathway linking posttranslational modification of Cav1.2, changes in channel clustering and function, they also raise a number of compelling unanswered questions. Given that functional channel coupling has been observed for many tissues where Cav1.2 is expressed, future directions will need to explore how universal this mechanism is throughout those tissues, as well as whether the other Cav isoforms utilize a similar signaling network to modulate channel clustering and cell function. Furthermore, PKA activation (and potentially Cav1.2 phosphorylation at S1928) resides downstream of a host of agonists and cell signaling pathways beyond glucose stimulation. It will be interesting going forward to determine the extent to which Cav1.2 phosphorylation at S1928 integrates stress stimuli upstream of PKA. Of course, perhaps the most pressing question for future work is to what extent can modulation of Cav1.2 S1928 phosphorylation and channel clustering mitigate vascular complications in the setting of diabetic hyperglycemia.
Sources of funding –
The authors are supported by the National Institutes of Health, grant numbers R01HL156652 (TJH), K99/R00 HL157684 (DMN); the Fondation Leducq THE FANTASY 19CV03; and the Bob and Corinne Frick Center for Heart Failure and Arrhythmia and Davis Heart and Lung Research Institute at the Ohio State University Wexner Medical Center.
Footnotes
Conflict of Interest Statement:
The authors declare that no conflicts of interest exist.
References
- 1.Baudel M, Flores-Tamez VA, Hong J, Reddy GR, Maillard P, Burns AE, Man KN, Sasse KC, Ward SM, Catterall WA, et al. Spatiotemporal control of vascular Cav1.2 by α1c S1928 phosphorylation. Circ Res. 2022;x:xxx–xxxx. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Catterall W. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol. 2000;16:521–55. [DOI] [PubMed] [Google Scholar]
- 3.Catterall WA. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 2011;3:a003947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dolphin AC. Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology. J Physiol. 2016;594:5369–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Navedo MF, Amberg GC, Votaw VS and Santana LF. Constitutively active L-type Ca2+ channels. Proc Natl Acad Sci U S A. 2005;102:11112–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Navedo MF, Amberg GC, Nieves M, Molkentin JD and Santana LF. Mechanisms underlying heterogeneous Ca2+ sparklet activity in arterial smooth muscle. J Gen Physiol. 2006;127:611–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Inoue M and Bridge JH. Ca2+ sparks in rabbit ventricular myocytes evoked by action potentials: involvement of clusters of L-type Ca2+ channels. Circ Res. 2003;92:532–8. [DOI] [PubMed] [Google Scholar]
- 8.Pfeiffer P, Egorov AV, Lorenz F, Schleimer JH, Draguhn A and Schreiber S. Clusters of cooperative ion channels enable a membrane-potential-based mechanism for short-term memory. Elife. 2020;9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dixon RE, Moreno CM, Yuan C, Opitz-Araya X, Binder MD, Navedo MF and Santana LF. Graded Ca(2)(+)/calmodulin-dependent coupling of voltage-gated CaV1.2 channels. Elife. 2015;4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Prada MP, Syed AU, Reddy GR, Martin-Aragon Baudel M, Flores-Tamez VA, Sasse KC, Ward SM, Sirish P, Chiamvimonvat N, Bartels P, et al. AKAP5 complex facilitates purinergic modulation of vascular L-type Ca(2+) channel CaV1.2. Nat Commun. 2020;11:5303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dixon RE, Navedo MF, Binder MD and Santana LF. Mechanisms and physiological implications of cooperative gating of clustered ion channels. Physiol Rev. 2022;102:1159–1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Clatot J, Hoshi M, Wan X, Liu H, Jain A, Shinlapawittayatorn K, Marionneau C, Ficker E, Ha T and Deschenes I. Voltage-gated sodium channels assemble and gate as dimers. Nat Commun. 2017;8:2077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Liu C, Ke P, Zhang J, Zhang X and Chen X. Protein Kinase Inhibitor Peptide as a Tool to Specifically Inhibit Protein Kinase A. Front Physiol. 2020;11:574030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bannister JP, Leo MD, Narayanan D, Jangsangthong W, Nair A, Evanson KW, Pachuau J, Gabrick KS, Boop FA and Jaggar JH. The voltage-dependent L-type Ca2+ (CaV1.2) channel C-terminus fragment is a bi-modal vasodilator. J Physiol. 2013;591:2987–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
